A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma
for Superficial Basal Cell Carcinoma
Sites in Webster +2 more locations
Sponsor: MediWound Ltd
Sex: All·Age: 18+
Code: NCT05157763·Phase 1, Phase 2·Recruiting·Listed Dec 2021